Akèy › Kansè Metastatik
Etid klinik pou Kansè Metastatik ap rekrite nan Etazini
283 etid pou Kansè Metastatik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX104 etid
- New York City, NY93 etid
- Nashville, TN70 etid
- Boston, MA63 etid
- Los Angeles, CA57 etid
- St. Louis, MO54 etid
- Arlington, VA53 etid
- Philadelphia, PA46 etid
- Chicago, IL45 etid
- San Antonio, TX44 etid
- Washington, DC43 etid
- Dallas, TX42 etid
- Seattle, WA39 etid
- Durham, NC33 etid
- Rochester, MN31 etid
- Pittsburgh, PA31 etid
- Baldwin Park, CA30 etid
- Cleveland, OH30 etid
- San Diego, CA30 etid
- Tampa, FL29 etid
- Orlando, FL29 etid
- Denver, CO29 etid
- Portland, OR29 etid
- Atlanta, GA28 etid
- Queens, NY28 etid
- San Francisco, CA28 etid
- Baltimore, MD28 etid
- Jacksonville, FL28 etid
- Columbus, OH27 etid
- Aurora, CO25 etid
- Mountain View, CA25 etid
- Detroit, MI24 etid
- Miami, FL24 etid
- New Haven, CT23 etid
- Grand Rapids, MI22 etid
- Madison, WI21 etid
- Salt Lake City, UT20 etid
- Phoenix, AZ20 etid
- Edison, NJ20 etid
- Orange, CA20 etid
Pa eta
- Alabama13 etid
- Arizona46 etid
- Arkansas14 etid
- Ayiti5 etid
- Colorado50 etid
- Connecticut27 etid
- Delaware8 etid
- Distrik Columbia24 etid
- Florid91 etid
- Georgia34 etid
- Idaho5 etid
- Illinois58 etid
- Indiana25 etid
- Iowa10 etid
- Kalifòni130 etid
- Kansas15 etid
- Kentucky17 etid
- Lwizyàn20 etid
- Main9 etid
- Maryland47 etid
- Massachusetts65 etid
- Michigan51 etid
- Minnesota40 etid
- Mississippi6 etid
- Missouri59 etid
- Montana4 etid
- Nebraska15 etid
- Nevada10 etid
- New Hampshire11 etid
- New Jersey44 etid
- New Mexico13 etid
- New York111 etid
- North Carolina52 etid
- North Dakota5 etid
- Ohio62 etid
- Oklahoma16 etid
- Oregon29 etid
- Pennsylvania68 etid
- Rhode Island9 etid
- South Carolina14 etid
- South Dakota10 etid
- Tennessee75 etid
- Texas139 etid
- Utah31 etid
- Vermont4 etid
- Virginia66 etid
- Washington47 etid
- West Virginia6 etid
- Wisconsin34 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Oct 2, 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07562152Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
Ap rekrite
Laj 15 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07856394Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05372614A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06270706A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07205822A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06234605A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 19 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06586957A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07213817TLR9 Immunotherapy for Peritoneal Carcinomatosis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07658196Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05287945Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06625775SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05222620PRE-ISPY Phase I/II Oncology Platform Program
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05868226A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07085091A Study of ASP3082 in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05382559First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05875168Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05803382Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05059678A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Ap rekriteFaz 1/2
Jiska laj 25 · Tout sèks · Mizajou Sep 25, 2026 · NCT04094610Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.